Literature DB >> 11406159

Chemical engineering of cell penetrating antibodies.

Y Zhao1, D Lou, J Burkett, H Kohler.   

Abstract

Antibodies, being exquisitely specific tools in biology, are routinely used to detect and identify intra-cellular structures. However, current intra-cellular application of antibodies requires that the membrane be rendered leaky, resulting in the death of cells. Here, we present a novel method to allow antibodies to penetrate the cellular membrane of living cells without affecting cell viability. A peptide (MTS, membrane transport sequence) that facilitates transport across membranes has been site-specifically attached to antibodies. MTS-antibodies enter the living cells in culture and can be detected by immunofluorescence and ELISA after extraction. Cellular structures are visualized in living cells using a specific MTS-antibody. Antibodies with membrane penetrating properties can become an important tool for the study of intra-cellular processes in living cells. Furthermore, such membrane penetrating antibodies can be used to selectively stimulate or suppress functions of the cellular machinery.

Mesh:

Substances:

Year:  2001        PMID: 11406159     DOI: 10.1016/s0022-1759(01)00410-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  13 in total

Review 1.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

Review 2.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

3.  Protective effects of anti-ricin A-chain antibodies delivered intracellularly against ricin-induced cytotoxicity.

Authors:  Feng Wu; Shaoan Fan; Frank Martiniuk; Seth Pincus; Sybille Müller; Heinz Kohler; Kam-Meng Tchou-Wong
Journal:  World J Biol Chem       Date:  2010-05-26

4.  Cationic surface modification of gold nanoparticles for enhanced cellular uptake and X-ray radiation therapy.

Authors:  Chaoming Wang; An Sun; Yong Qiao; Peipei Zhang; Liyuan Ma; Ming Su
Journal:  J Mater Chem B       Date:  2015-08-19       Impact factor: 6.331

5.  Structural conservation in band 4.1, ezrin, radixin, moesin (FERM) domains as a guide to identify inhibitors of the proline-rich tyrosine kinase 2.

Authors:  Nathalie Meurice; Lei Wang; Christopher A Lipinski; Zhongbo Yang; Christopher Hulme; Joseph C Loftus
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

6.  The Pyk2 FERM domain as a target to inhibit glioma migration.

Authors:  Joseph C Loftus; Zhongbo Yang; Nhan L Tran; Jean Kloss; Carole Viso; Michael E Berens; Christopher A Lipinski
Journal:  Mol Cancer Ther       Date:  2009-06-09       Impact factor: 6.261

Review 7.  Targeted Intracellular Delivery of Antibodies: The State of the Art.

Authors:  Tatiana A Slastnikova; A V Ulasov; A A Rosenkranz; A S Sobolev
Journal:  Front Pharmacol       Date:  2018-10-24       Impact factor: 5.810

8.  Single domain intrabodies against WASP inhibit TCR-induced immune responses in transgenic mice T cells.

Authors:  Mitsuru Sato; Ryoko Sawahata; Chisato Sakuma; Takato Takenouchi; Hiroshi Kitani
Journal:  Sci Rep       Date:  2013-10-21       Impact factor: 4.379

9.  A Cell Internalizing Antibody Targeting Capsid Protein (p24) Inhibits the Replication of HIV-1 in T Cells Lines and PBMCs: A Proof of Concept Study.

Authors:  Syed A Ali; Sin-Yeang Teow; Tasyriq Che Omar; Alan Soo-Beng Khoo; Tan Soo Choon; Narazah Mohd Yusoff
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

10.  A Novel Cell-Penetrating Antibody Fragment Inhibits the DNA Repair Protein RAD51.

Authors:  Landon Pastushok; Yongpeng Fu; Leo Lin; Yu Luo; John F DeCoteau; Ken Lee; C Ronald Geyer
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.